Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses

Harrison P. Nguyen, BA; Jason K. Rivers, MD, FRCPC, FAAD

Disclosures

Skin Therapy Letter. 2016;21(3) 

In This Article

Conclusion

5-FU-SA represents a new addition to our treatment of AK, especially for individuals who want to avoid the pain or potential consequences associated with destructive therapy for isolated lesions. An emerging role for 5-FU-SA may be in combination therapy with other agents that have been unsuccessful in clearing hyperkeratotic lesions in the treatment zone.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....